Search Results 1791-1800 of 18758 for Relapse
Patient must have relapsed or refractory to, intolerant to, or are considered ineligible for therapies known to provide clinical benefit. In addition, a ...
... relapsed or refractory chronic lymphocytic leukemia (rrCLL), multiple myeloma (rrMM), or diffuse large B-cell lymphoma (rrDLBCL) in up to 138 participants ...
Currently, six different CAR -T cell therapies are approved for treating relapsed blood cancers. Most patients have impressive response rates, but not ...
A previous phase 1 study showed that the vaccine was safe and induced a higher than expected rate of relapse-free survival in ovarian cancer in first remission.
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial. J Thorac Oncol ...
And tolerating the drug well. Although I have stopped hoping for a cure (I have even stopped counting the number of times I was in remission and then relapsed), ...
Relapse within 3 months of completion of prior adjuvant or neoadjuvant chemotherapy; Any prior chemotherapy in the metastatic setting with the exception of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.